Literature DB >> 18679656

The effect of long-term repeated exposure to 3,4-methylenedioxymethamphetamine on cardiovascular and thermoregulatory changes.

Emily Joy Jaehne1, Abdallah Salem, Rodney James Irvine.   

Abstract

RATIONALE: 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") disrupts thermoregulation in rats and can lead to life-threatening hyperthermia in humans. MDMA administration can also lead to long-term neurotoxicity in animals and possibly humans.
OBJECTIVES: The purpose of the current study was to extend previous results on the acute effects of MDMA on behavioral thermoregulation to a repeated dosing regime, simulating regular weekend use of ecstasy, on measures of thermoregulation and heart rate (HR).
MATERIALS AND METHODS: Sprague-Dawley rats with telemetry implants were administered 40 micromol/kg MDMA on three consecutive days each week for 1 or 6 weeks before being confined to an elevated ambient temperature (TA) (HOT; 30+/-1 degrees C) or an area at room temperature (ROOM; 21.5+/-1.5 degrees C) for 30 min. After the final drug administration, rats were placed in a thermal gradient for 4 h to allow behavioral thermoregulation.
RESULTS: HOT rats showed higher core temperature (TC), HR, and locomotor activity than ROOM rats during confinement to a set TA (P<0.001). HR responses to MDMA over 6 weeks at both TAs progressively decreased with repeated dosing (P<0.05). TC was significantly higher in both 6-week groups compared to the 1-week groups (P<0.05) at the end of time in the gradient. Cortical concentrations of dihydroxyphenylacetic acid (DOPAC; P<0.05) and 5-hydroxyindole acetic acid (5-HIAA; P<0.001) decreased significantly irrespective of TA, while concentrations of dopamine and 5-HT did not change.
CONCLUSION: Long-term treatment with MDMA resulted in apparent tolerance to the effects of the drug on HR, dysregulation of TC in thermal gradient, and depletion of cortical DOPAC and 5-HIAA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18679656     DOI: 10.1007/s00213-008-1258-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  41 in total

1.  Selective changes in the contents of noradrenaline, dopamine and serotonin in rat brain areas during aging.

Authors:  J M Míguez; M Aldegunde; L Paz-Valiñas; J Recio; E Sánchez-Barceló
Journal:  J Neural Transm (Vienna)       Date:  1999       Impact factor: 3.575

2.  A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration.

Authors:  M Shankaran; G A Gudelsky
Journal:  Psychopharmacology (Berl)       Date:  1999-11       Impact factor: 4.530

3.  Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial.

Authors:  S J Lester; M Baggott; S Welm; N B Schiller; R T Jones; E Foster; J Mendelson
Journal:  Ann Intern Med       Date:  2000-12-19       Impact factor: 25.391

4.  Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine.

Authors:  Paul D Callaghan; Kirsten Farrand; Abdallah Salem; Patrick Hughes; Lynette C Daws; Rodney J Irvine
Journal:  Eur J Pharmacol       Date:  2006-07-25       Impact factor: 4.432

5.  Cardiovascular and metabolic responses of hypertensive and normotensive rats to one week of cold exposure.

Authors:  J B Chambers; T D Williams; A Nakamura; R P Henderson; J M Overton; M E Rashotte
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-10       Impact factor: 3.619

6.  Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.

Authors:  Veronica Sanchez; Esther O'shea; Kathryn S Saadat; J Martin Elliott; M Isabel Colado; A Richard Green
Journal:  J Psychopharmacol       Date:  2004-09       Impact factor: 4.153

7.  Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

Authors:  U D McCann; Z Szabo; U Scheffel; R F Dannals; G A Ricaurte
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

8.  The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').

Authors:  E O'Shea; R Granados; B Esteban; M I Colado; A R Green
Journal:  Neuropharmacology       Date:  1998-07       Impact factor: 5.250

Review 9.  The health effects of ecstasy: a literature review.

Authors:  Linda R Gowing; Susan M Henry-Edwards; Rodney J Irvine; Robert L Ali
Journal:  Drug Alcohol Rev       Date:  2002-03

10.  Circadian variations in the monoamine levels and monoamine oxidase activity in different regions of the rat brain as a function of age.

Authors:  D Bhaskaran; E Radha
Journal:  Exp Gerontol       Date:  1984       Impact factor: 4.032

View more
  5 in total

Review 1.  The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives.

Authors:  J R Docherty; A R Green
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

2.  Neuronal nitric oxide synthase within paraventricular nucleus: blood pressure and baroreflex in two-kidney, one-clip hypertensive rats.

Authors:  Noreen F Rossi; Maria Maliszewska-Scislo; Haiping Chen; Stephen M Black; Shruti Sharma; Ruslan Ravikov; Robert A Augustyniak
Journal:  Exp Physiol       Date:  2010-05-21       Impact factor: 2.969

Review 3.  Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?

Authors:  Noreen T Boyle; Thomas J Connor
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 4.  Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.

Authors:  João Paulo Capela; Helena Carmo; Fernando Remião; Maria Lourdes Bastos; Andreas Meisel; Félix Carvalho
Journal:  Mol Neurobiol       Date:  2009-04-17       Impact factor: 5.590

5.  Behavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxymethamphetamine ("Ecstasy") self-administration.

Authors:  Maria Elena Reveron; Esther Y Maier; Christine L Duvauchelle
Journal:  Behav Brain Res       Date:  2009-11-03       Impact factor: 3.332

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.